Stichting Centre for Human Drug Research (CHDR)

Algemene informatie

CHDR specializes in conducting early-phase clinical studies, particularly studies that are data intensive and include pharmacokinetic and pharmacodynamic parameters. CHDR can perform first-in-man, single- and multiple-dose, food or drug interaction, proof-of-pharmacology, imaging (PET, MRI), QTc, and proof-of-concept studies. Additionally, CHDR has experience in PK/PD studies with bio-similars and bio-betters.

CHDR’s facilities include a state-of-the-art Phase 1/2 unit with a licensed pharmacy and clinical chemical lab. CHDR has the capability to conduct specialized assessments on site in a variety of therapeutic areas including neurology, psychiatry, cardiology, hematology, respiratory, and metabolic disease, and has an established database of both healthy volunteers and specific-disease subject groups. CHDR conducts both adult and pediatric studies.